Johan Richter
Overview
Explore the profile of Johan Richter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
2161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klint E, Richter J, Milos P, Hallbeck M, Wardell K
Neurooncol Adv
. 2024 Dec;
6(1):vdae175.
PMID: 39687792
Background: Brain tumor needle biopsy interventions are inflicted with nondiagnostic or biased sampling in up to 25% and hemorrhage, including asymptomatic cases, in up to 60%. To identify diagnostic tissue...
2.
Warfvinge R, Geironson Ulfsson L, Dhapola P, Safi F, Sommarin M, Soneji S, et al.
Elife
. 2024 Nov;
12.
PMID: 39503729
The advent of tyrosine kinase inhibitors (TKIs) as treatment of chronic myeloid leukemia (CML) is a paradigm in molecularly targeted cancer therapy. Nonetheless, TKI-insensitive leukemia stem cells (LSCs) persist in...
3.
Wardell K, Richter J, Zsigmond P
Microcirculation
. 2024 Sep;
31(8):e12884.
PMID: 39340816
Laser Doppler flowmetry (LDF) is a well-established technique for the investigation of tissue microcirculation. Compared to skin, the use in the human brain is sparse. The measurement of cerebral microcirculation...
4.
Efficace F, Mahon F, Richter J, Piciocchi A, Cipriani M, Nicolini F, et al.
Leukemia
. 2024 Jul;
38(8):1722-1730.
PMID: 38987274
Limited data is available on the health-related quality of life (HRQoL) and symptoms of patients with chronic myeloid leukemia (CML) who are in treatment-free remission (TFR). We herein report HRQoL...
5.
Mahon F, Pfirrmann M, Dulucq S, Hochhaus A, Panayiotidis P, Almeida A, et al.
J Clin Oncol
. 2024 Mar;
42(16):1875-1880.
PMID: 38471049
JCO The European Stop Kinase Inhibitors (EURO-SKI) study is the largest clinical trial for investigating the cessation of tyrosine kinase inhibitors (TKIs) in patients with chronic myeloid leukemia in stable...
6.
Flygt H, Soderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, et al.
Leukemia
. 2024 Feb;
38(4):925.
PMID: 38418611
No abstract available.
7.
Flygt H, Soderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, et al.
Leukemia
. 2024 Jan;
38(4):781-787.
PMID: 38278960
Tyrosine kinase inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML) has become part of routine care for patients with a sustained deep molecular response (DMR). Approximately 50% experience a molecular...
8.
Pfirrmann M, Saussele S, Mahon F, Richter J
Leukemia
. 2024 Jan;
38(2):460-462.
PMID: 38172328
No abstract available.
9.
Polakova K, Albeer A, Polivkova V, Krutska M, Vlcanova K, Curik N, et al.
Leukemia
. 2023 Dec;
38(2):318-325.
PMID: 38129513
Membrane transporters are important determinants of drug bioavailability. Their expression and activity affect the intracellular drug concentration in leukemic cells impacting response to therapy. Pharmacogenomics represents genetic markers that reflect...
10.
Klint E, Richter J, Wardell K
Brain Sci
. 2023 May;
13(5).
PMID: 37239281
Brain tumor needle biopsies are performed to retrieve tissue samples for neuropathological analysis. Although preoperative images guide the procedure, there are risks of hemorrhage and sampling of non-tumor tissue. This...